This webinar will highlighted recent developments in the management of both squamous and glandular gastric disease, reviewing recent publications in the context of existing knowledge. Attendees gain an understanding of the limitations of oral proton pump inhibitors and explore advances in newer generation PPIs, including extended-release injectable omeprazole. The session also covered the published evidence supporting a range of treatment options for gastric disease.
